3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, B-Cell
2
Leukemia
2
Recurrence
1
Neoplasms
1
Motor Activity
1
Lymphoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Hairy Cell
1
Diabetes Mellitus
1
Interventions
Exercise
27
Resistance Training
3
Physical Therapy Modalities
2
Methods
2
Diet
2
Wearable Electronic Devices
1
Waiting Lists
1
Tablets
1
Surveys and Questionnaires
1
Roflumilast
1
Rehabilitation
1
Psychosocial Intervention
1
Psychology, Positive
1
Preoperative Exercise
1
Nutritional Support
1
Nutritional Status
1
Nadolol
1
Masks
1
Isoproterenol
1
Exercise Therapy
1
Dosage Forms
1
Carvedilol
1
Bisoprolol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Motor Activity
×
Tablets
×
Other hematologic neoplasm
×
Clear all
NCT06643221
2026-06-05
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
200 enrolled